Molecular staging of surgical margins after radical prostatectomy by detection of telomerase activity

Prostate

Volumn 49, Issue 2, 2001, Pages 140-144

  Straub, Bernd ^a   Müller, Markus ^a   Krause, Hans ^a   Goessl, Carsten ^a   Schrader, Mark ^a   Heicappell, Rüdiger ^a   Miller, Kurt ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Human prostate cancer; Polymerase chain reaction; Staging; Telomerase activity

Indexed keywords

TELOMERASE;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; DISEASE MARKER; ENZYME ACTIVITY; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATECTOMY; TELOMERE;

BIOPSY; CARCINOMA; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034786730     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.1128     Document Type: Article

References (33)

1. Prostate cancer screening in the Tyrol, Austria: Experience and results
2. Prognostic markers in clinically localised prostate cancer
3. Pathological characteristics and prognosis of nonpalpable and palpable prostate cancers with a Hybritech prostate specific antigen of 4 to 10 ng/ml
4. Prostate-specific antigen-detected prostate cancer (stage T1c): An analysis of whole-mount prostatectomy specimens
5. Role of radical prostatectomy in patients with prostate cancer of high Gleason score
6. Optimizing patients selection for dose escalation techniques using the prostate-specific antigen level, biopsy Gleason score, and clinical T-stage
7. Preoperative predicition of surgical margin status in patients with prostate cancer treated by radical prostatectomy
8. Results of hospital cancer registry by the American College of Surgeons: Outcomes of prostate cancer treatment by radical prostatectomy
9. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma
10. Positive surgical margins with radical retropubic prostatectomy: Anatomic site-specific pathologic analysis and impact on prognosis
11. Prognostic implications of a positive apical margin in radical prostatectomy specimens
12. Management of a positive surgical margin after radical prostatectomy: Decision analysis
13. Interphase cytogenetic study of preoperative core biopsies for the prediction of early serum prostate specific antigen recurrence after radical prostatectomy of clinically localized prostate carcinoma
14. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: Epidemiologic significance of annual changes
15. Radical prostatectomy for prostate cancer: The perineal approach increases the risk of surgically induced positive margins and capsular incisions
16. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer
17. Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up
18. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin
19. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary treatment: Data from the CaPSURE database
20. How to explore the patient with a rising PSA after radical prostatectomy: Defining local versus systemic failure
21. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer
22. Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation
23. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy
24. Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer
25. The detection of prostate cells by the reverse transcription-polymerase chain reaction in the circulation of patients undergoing transurethral resection of the prostate
26. Molecular staging of prostate cancer: Dream or reality?
27. A survey of telomerase activity in human cancer
28. Telomerase activity: A prevalent marker of malignant human prostate tissue
29. Telomerase activity in primary prostate cancer
30. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium
31. Telomerase activity in malignant and benign renal tumors
32. Specific association of human telomerase activity with immortal cells and cancer
33. An appraisal of telomerase activity in benign prostatic hyperplasia